Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.04 USD | +0.05% | -2.07% | -10.56% |
Apr. 11 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
Apr. 03 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.56% | 1.65B | |
+27.33% | 672B | |
+24.27% | 550B | |
-7.07% | 351B | |
+15.17% | 317B | |
+6.34% | 292B | |
+2.66% | 211B | |
-0.15% | 203B | |
-11.57% | 144B | |
-8.53% | 141B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Jefferies Downgrades Harmony Biosciences Holdings to Hold From Buy; Price Target is $57